"Designing Growth Strategies is in our DNA"

Regenerative Medicine Market Size, Share & COVID-19 Impact Analysis, By Product (Cell Therapy, Gene Therapy, Tissue Engineering, and Platelet Rich Plasma), By Application (Orthopedics, Wound Care, Oncology, Rare Diseases, and Others), By Distribution Channel (Hospitals, Clinics, and Others), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI100970

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Global Financing of Companies Active in Regenerative Medicine
    2. Prevalence of Chronic Diseases, by Key Countries/Regions, 2021
    3. Pipeline Analysis, By Key Players
    4. New Product Launches
    5. Key Industry Developments: Mergers, Acquisitions & Partnerships
    6. Technological Developments
    7. Impact of COVID-19 on the Global Regenerative Medicine Market
  5. Global Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Regenerative Medicine Market Analysis, Insights and Forecast, 2019-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Product
      1. Cell Therapy
      2. Gene Therapy
      3. Tissue Engineering
      4. Platelet Rich Plasma
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Wound Care
      3. Oncology
      4. Rare Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Clinics
      3. Others
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Integra LifeSciences Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Bristol-Myers Squibb Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Tissue Regenix
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Smith & Nephew
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. MiMedx 
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Allergan Aesthetics (AbbVie Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Stryker
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. American CryoStem Corporation
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Kite (Gilead Sciences, Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      11. AlloSource
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      12. bluebird bio, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      13. CRISPR Therapeutics
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      14. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      15. Tegoscience
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Regenerative Medicine Market Value Share (%), By Product, 2021 & 2029

Figure 2:  Global Regenerative Medicine Market Value Share (%), By Application, 2021 & 2029

Figure 3:  Global Regenerative Medicine Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 4:  Global Regenerative Medicine Market Value (USD billion), By Region, 2021 & 2029

Figure 5:  North America Regenerative Medicine Market Value (USD billion), by Product, 2021 & 2029

Figure 6:  North America Regenerative Medicine Market Value Share (%), by Product, 2021

Figure 7:  North America Regenerative Medicine Market Value (USD billion), by Application, 2021 & 2029

Figure 8:  North America Regenerative Medicine Market Value Share (%), by Application, 2021

Figure 9:  North America Regenerative Medicine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 10:  North America Regenerative Medicine Market Value Share (%), by Distribution Channel, 2021

Figure 11:  North America Regenerative Medicine Market Value (USD billion), by Country, 2021 & 2029

Figure 12:  North America Regenerative Medicine Market Value Share (%), by Country, 2021

Figure 13:  Europe Regenerative Medicine Market Value (USD billion), by Product, 2021 & 2029

Figure 14:  Europe Regenerative Medicine Market Value Share (%), by Product, 2021

Figure 15:  Europe Regenerative Medicine Market Value (USD billion), by Application, 2021 & 2029

Figure 16:  Europe Regenerative Medicine Market Value Share (%), by Application, 2021

Figure 17:  Europe Regenerative Medicine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 18:  Europe Regenerative Medicine Market Value Share (%), by Distribution Channel, 2021

Figure 19: Europe Regenerative Medicine Market Value (USD billion), by Country/ Sub-Region, 2021 & 2029

Figure 20:  Europe Regenerative Medicine Market Value Share (%), by Country/ Sub-Region, 2021

Figure 21:  Asia Pacific Regenerative Medicine Market Value (USD billion), by Product, 2021 & 2029

Figure 22:  Asia Pacific Regenerative Medicine Market Value Share (%), by Product, 2021

Figure 23:  Asia Pacific Regenerative Medicine Market Value (USD billion), by Application, 2021 & 2029

Figure 24:  Asia Pacific Regenerative Medicine Market Value Share (%), by Application, 2021

Figure 25: Asia Pacific Regenerative Medicine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 26: Asia Pacific Regenerative Medicine Market Value Share (%), by Distribution Channel, 2021

Figure 27:  Asia Pacific Regenerative Medicine Market Value (USD billion), by Country/ Sub-Region, 2021 & 2029

Figure 28: Asia Pacific Regenerative Medicine Market Value Share (%), by Country/ Sub-Region, 2021

Figure 29:  Latin America Regenerative Medicine Market Value (USD billion), by Product, 2021 & 2029

Figure 30:  Latin America Regenerative Medicine Market Value Share (%), by Product, 2021

Figure 31:  Latin America Regenerative Medicine Market Value (USD billion), by Application, 2021 & 2029

Figure 32:  Latin America Regenerative Medicine Market Value Share (%), by Application, 2021

Figure 33:  Latin America Regenerative Medicine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 34: Latin America Regenerative Medicine Market Value Share (%), by Distribution Channel, 2021

Figure 35:  Latin America Regenerative Medicine Market Value (USD billion), by Country/ Sub-Region, 2021 & 2029

Figure 36: Latin America Regenerative Medicine Market Value Share (%), by Country/ Sub-Region, 2021

Figure 37: Middle East & Africa Regenerative Medicine Market Value (USD billion), by Product, 2021 & 2029

Figure 38:  Middle East & Africa Regenerative Medicine Market Value Share (%), by Product, 2021

Figure 39: Middle East & Africa Regenerative Medicine Market Value (USD billion), by Application, 2021 & 2029

Figure 40: Middle East & Africa Regenerative Medicine Market Value Share (%), by Application, 2021

Figure 41: Middle East & Africa Regenerative Medicine Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 42: Middle East & Africa Regenerative Medicine Market Value Share (%), by Distribution Channel, 2021

Figure 43: Middle East & Africa Regenerative Medicine Market Value (USD billion), by Country/ Sub-Region, 2021 & 2029

Figure 44:  Middle East & Africa Regenerative Medicine Market Value Share (%), by Country/ Sub-Region, 2021

Table 1:  Global Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 2: Global Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 3: Global Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 4:  Global Regenerative Medicine Market Revenue (USD billion) Forecast, By Region, 2018-2029

Table 5:  North America Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 6:  North America Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 7:  North America Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 8:  North America Regenerative Medicine Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 9:  Europe Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 10: Europe Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 11: Europe Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 12:  Europe Regenerative Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2018-2029

Table 13: Asia Pacific Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 14: Asia Pacific Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 15: Asia Pacific Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 16: Asia Pacific Regenerative Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2018-2029

Table 17:  Latin America Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 18:  Latin America Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 19:  Latin America Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 20:  Latin America Regenerative Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2018-2029

Table 21:  Middle East & Africa Regenerative Medicine Market Revenue (USD billion) Forecast, By Product, 2018-2029

Table 22:  Middle East & Africa Regenerative Medicine Market Revenue (USD billion) Forecast, By Application, 2018-2029

Table 23:  Middle East & Africa Regenerative Medicine Market Revenue (USD billion) Forecast, By Distribution Channel, 2018-2029

Table 24:  Middle East & Africa Regenerative Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2018-2029

  • Dec, 2022
  • 2021
  • 2018-2020
  • 192

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X